Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer.

Chen, Yang; Jia, Keren; Chong, Xiaoyi; Xie, Yi; Jiang, Lei; Peng, Haoxin; Liu, Dan; Yuan, Jiajia; Li, Yanyan; Feng, Xujiao; Sun, Yu; Li, Jian; Zhang, Xiaotian; Shen, Lin

Chen, Yang; Jia, Keren; Chong, Xiaoyi; Xie, Yi; Jiang, Lei; Peng, Haoxin; Liu, Dan; Yuan, Jiajia; Li, Yanyan; Feng, Xujiao; Sun, Yu; Li, Jian; Zhang, Xiaotian; Shen, Lin.

Affiliation

Chen Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Jia K; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Chong X; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Xie Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Jiang L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Peng H; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Liu D; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Yuan J; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Li Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Feng X; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Sun Y; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Li J; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Zhang X; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China. zhangxiaotian@bjmu.edu.cn.
Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China. shenlin@bjmu.edu.cn.

Mol Cancer ; 23(1): 169, 2024 Aug 20.

Article in En | MEDLINE | ID: mdl-39164705

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Receptor, ErbB-2 / Tumor Microenvironment / B7-H1 Antigen Limits: Female / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google